Delivery Order SPE2DB20D1004-SPE2DB25FNLCC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $3,693.91. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 10, 2025, and was awarded on a competitive basis without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $12,435.70 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of HYZAAR 50-12.5 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $1,504.02 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30-count units). This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a $15,164.14 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Hyzaar 50-12.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $341,650 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561599439 HYZAAR 100-12.5 mg tablets. Under this order, Amerisourcebergen will deliver 90 tablets of the specified hypertension medication to a facility in Conshohocken, Pennsylvania by July 26, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on the Agency's Pharmaceutical Prime Vendor contract,...
- The Defense Logistics Agency Troop Support Medical awarded a $123,480 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561562810 HYZAAR 50-12.5MG 90S tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania by July 24, 2023 in support of the Defense Logistics Agency's medical supply chain initiatives. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $2,155.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of HYZAAR 100-12.5, a combination antihypertensive medication, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $2,032.02. The order is for 4562654971 HYZAAR 100-25 TABLET 30S to be delivered by November 1, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and DLA Troop...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNLCCDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $2,083.81, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a wide range of pharmaceutical products and medical supplies to military and veteran healthcare systems. As the prime contractor on the SPE2DX IDC, the company fulfills delivery orders for medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for HYZAAR—a common antihypertensive medication used to treat high blood pressure—exemplifies the routine pharmaceutical supply operations conducted through this flexible contract vehicle to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/26/25 |